OPEN Health is proud to announce that its near-term and net-zero emission reduction targets have been officially validated by the Science Based Targets initiative (SBTi). Read the press release for more information.
OPEN Health, a global leader in medical affairs, health economics and outcomes research (HEOR) and market access, patient engagement, and consulting services, has appointed Zack Lentz as Chief Commercial Officer. Lentz brings more than two decades of experience building and leading high-performing teams across the life sciences sector. At OPEN Health, he will focus on accelerating growth, deepening client partnerships, and ensuring clients realize the full value of the company’s integrated capabilities. Before joining OPEN Health, Lentz held senior leadership roles including Chief Growth Officer at Inizio Medical and President & Chief Strategy Officer at Vaniam Group. His career reflects the evolution of the pharmaceutical and biotech industries from the blockbuster era to today’s patient-centered model, which unites precision science with evidence, access, and engagement to deliver real-world impact.
At OPEN Health, we connect visionary minds, pioneering science, and advanced technology to drive real impact. By uniting people, science, and technology, we activate new opportunities for biopharma innovation. Our expertise across medical affairs and market access unlocks faster, smarter routes to market. We are committed to improving patient outcomes worldwide. OPEN Health. The right combination to unlock possibilities. To learn more, visit www.openhealthgroup.com
As a purpose-driven company, we are committed to continually raising our ethical and sustainability standards and aligning our values with those of our clients. We are proud to share our 2024 IMPACT report, highlighting the achievements we’ve made in our sustainability journey over the past year. Read our 2024 report here: https://indd.adobe.com/view/93df9f14-d7d4-4d56-a37b-7b25e09c0a27
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy. Click to read more.
OPEN Health today announced a multiyear, mission-level corporate partnership with ISPOR – The Professional Society for Health Economics and Outcomes Research. This partnership underscores OPEN Health’s commitment to being a global leader in HEOR and market access and supporting ISPOR’s vital mission to advance HEOR excellence, ultimately improving decision-making for better health worldwide. Click to read more.
OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center. OPEN Health’s Solution Innovation Center (SIC) consists of a cross-functional team that leverages technology partnerships to combine scientific expertise and proprietary product development to advance biopharmaceutical innovation in Medical Affairs and market access. Click to read more: https://www.openhealthgroup.com/news/05-02-2025/open-health-appoints-david-sakadelis-as-chief-technology-officer/
OPEN Health is excited to announce the upcoming presentation of a collection of research supported by its Scientific Buyout Program. This initiative empowers our team members to dedicate time toward innovative projects in HEOR and market access. We're proud to invest in our team's growth and scientific excellence. Read more here: https://www.openhealthgroup.com/news/11-11-2024/open-health-presents-first-collection-of-research-backed-by-scientific-buyout-fund-to-foster-research-and-development/
Unlock possibilities in HEOR & Market Access with OPEN Health at ISPOR Europe 2024. Connect with our teams at the upcoming ISPOR Europe 2024 conference. Our experts will present on a range of critical topics, including advanced survival modeling techniques and strategies to transform robust patient preference data into decision-ready insights.
Last week, our Rotterdam office hosted the second annual Modeling and Meta Analysis (MMA) Summer School, bringing together 40 talented participants from across the globe—including the US, India, UK, Germany, Belgium, and the Netherlands. Over three engaging days, attendees took part in dynamic training sessions on health economic models, data analytics, and more. Beyond professional growth, the Summer School was a fantastic opportunity for many colleagues to meet in person for the first time, exchange knowledge, share best practices and have fun. Click to go our career page to explore more opportunities.
